Y-Mabs Therapeutics Inc (YMAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2020 | 03-2020 | 12-2019 | 09-2019 | 06-2019 | |
| Operating Expenses | 40,452 | 26,747 | 23,758 | 24,359 | 18,634 |
| Operating Income | -40,452 | -26,747 | -23,758 | -24,359 | -18,634 |
| Other Income | 59 | 568 | 622 | 437 | 598 |
| Pre-tax Income | -40,393 | -26,179 | -23,136 | -23,922 | -18,036 |
| Net Income Continuous | -40,393 | -26,179 | -23,136 | -23,922 | -18,036 |
| Net Income | $-40,393 | $-26,179 | $-23,136 | $-23,922 | $-18,036 |
| EPS Basic Total Ops | -1.01 | -0.66 | -0.60 | -0.70 | -0.53 |
| EPS Basic Continuous Ops | -1.01 | -0.66 | -0.61 | -0.70 | -0.53 |
| EPS Diluted Total Ops | -1.01 | -0.66 | -0.60 | -0.70 | -0.53 |
| EPS Diluted Continuous Ops | -1.01 | -0.66 | -0.61 | -0.70 | -0.53 |
| EBITDA(a) | $-40,352 | $-26,661 | $-23,679 | $-24,311 | $-18,614 |